Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for iSpecimen (ISPC) over the last 4 years, with Sep 2025 value amounting to -6.67%.

  • iSpecimen's Return on Capital Employed fell 484.00% to -6.67% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.67%, marking a year-over-year decrease of 484.00%. This contributed to the annual value of -1.87% for FY2024, which is 108.00% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Return on Capital Employed is -6.67%, which was up 23.16% from -8.68% recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Return on Capital Employed ranged from a high of -0.23% in Q1 2022 and a low of -8.68% during Q2 2025.
  • Moreover, its 3-year median value for Return on Capital Employed was -1.60% (2024), whereas its average is -2.70%.
  • Data for iSpecimen's Return on Capital Employed shows a maximum YoY tumbled of 708bps (in 2025) over the last 5 years.
  • Over the past 5 years, iSpecimen's Return on Capital Employed (Quarterly) stood at -0.25% in 2021, then dropped by 22bps to -0.46% in 2022, then plummeted by 65bps to -1.12% in 2023, then slumped by 169bps to -2.81% in 2024, then crashed by 484bps to -6.67% in 2025.
  • Its last three reported values are -6.67% in Q3 2025, -8.68% for Q2 2025, and -3.58% during Q1 2025.